Phase II Study of Regorafenib in Metastatic Soft Tissue Sarcoma (Q65362408)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II Study of Regorafenib in Metastatic Soft Tissue Sarcoma |
clinical trial |
Statements
REGO-SARC (English)
0 references
Activity and Safety of Regorafenib in Patients With Metastatic Soft Tissue Sarcoma Previously Treated With Anthracycline-based Chemotherapy : a Multinational, Randomized, Phase II, Placebo-controlled Trial (English)
0 references
5 June 2013
0 references
February 2019
0 references
219
0 references
18 year
0 references